Date
November 14–19, 2024
Venue
Walter E. Washington Convention Center
Washington, D.C.
The American College of Rheumatology (ACR) Convergence 2024 is set for November 14-19 in Washington, D.C., at the Walter E. Washington Convention Center. Recognized as one of the largest and most influential rheumatology conferences worldwide, it gathers experts, researchers, and clinicians to share the latest advances in diagnosing, managing, and treating rheumatic diseases. Attendees will experience an array of scientific sessions, including active learning opportunities that encourage direct audience engagement, networking lounges, and specialized workshops to facilitate collaboration and knowledge sharing.
AbolerIS Pharma will be attending this prestigious event in Washington, D.C. Dr. Carole Guillonneau will also give a poster presentation, titled “Elimination of CD45RChigh T and B cells by an anti-CD45RC antibody leads to efficient control of experimental rheumatoid arthritis.”
